These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2335494)

  • 1. Afternoon fatigue and somnolence associated with tranylcypromine treatment.
    Joffe RT
    J Clin Psychiatry; 1990 May; 51(5):192-3. PubMed ID: 2335494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tranylcypromine on the sleep of patients with anergic bipolar depression.
    Jindal RD; Fasiczka AL; Himmelhoch JM; Mallinger AG; Thase ME
    Psychopharmacol Bull; 2003; 37(3):118-26. PubMed ID: 14608244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose tranylcypromine therapy for refractory depression.
    Amsterdam JD; Berwish NJ
    Pharmacopsychiatry; 1989 Jan; 22(1):21-5. PubMed ID: 2710808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Jones DE; Newton JL
    Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranylcypromine: patterns and predictors of response.
    White K; White J
    J Clin Psychiatry; 1986 Jul; 47(7):380-2. PubMed ID: 3522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinduction of hypertensive reactions by tranylcypromine?
    Keck PE; Pope HG; Nierenberg AA
    J Clin Psychopharmacol; 1989 Feb; 9(1):48-51. PubMed ID: 2486182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbances in relation to fatigue in major depression.
    Ferentinos P; Kontaxakis V; Havaki-Kontaxaki B; Paparrigopoulos T; Dikeos D; Ktonas P; Soldatos C
    J Psychosom Res; 2009 Jan; 66(1):37-42. PubMed ID: 19073291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.
    Newton JL; Gibson GJ; Tomlinson M; Wilton K; Jones D
    Hepatology; 2006 Jul; 44(1):91-8. PubMed ID: 16800007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.